Unlicensed and off-label drug use in an Australian neonatal intensive care unit.
about
Innovative clinical trial design for pediatric therapeuticsClinical setting influences off-label and unlicensed prescribing in a paediatric teaching hospitalClinical trials of drugs used off-label in neonates: ethical issues and alternative study designs.Licensing and labelling of drugs in a paediatric oncology ward.Trends in accessibility to medicines for children in New Zealand: 1998-2002.Unlicensed and Off-Label Drug Use in Children Before and After Pediatric Governmental InitiativesPaediatric drug use with focus on off-label prescriptions at Swedish hospitals - a nationwide study.The effects of environmental noise and infant position on cerebral oxygenation.Drug Utilisation Patterns in Children Admitted to a Paediatric General Medical Ward in Five Countries.Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety.Challenges in Treating Low Blood Pressure in Preterm InfantsUse of non-formulary drugs in children at a Brazilian teaching hospital: a descriptive study.The physician's role and responsibility in reporting adverse drug events in children.Magistral drugs in hospitalized newborns and children.Drug labeling and exposure in neonatesAdverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future.Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey.Off-label drug use in pediatric patients.Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review.Changes in availability of paediatric medicines in Australia between 1998 and 2002.Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future.Review of drug utilization patterns in NICUs worldwide.Drug utilisation profile in the neonatal unit of a university hospital: a prospective observational study in Brazil.Safer prescribing for children.Unlicensed and off-label drug use in a neonatal unit in France.Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia.Unlicensed and off-label drug use in an Irish neonatal intensive care unit: a prospective cohort study.Discontinuities and disruptions in drug dosage guidelines for the paediatric population.How are we assessing the safety and quality use of medicines used by young people in Australia?Large differences in neonatal drug use between NICUs are common practice: time for consensus?Off-label drug use in a single-center pediatric cardiac intensive care unit.Loratidine buccal films for allergic rhinitis: development and evaluationOff-label use of medicines in paediatric inpatients at an Australian teaching hospitalUse of off-label and unlicensed medicines in neonatal intensive care
P2860
Q24635308-B8726372-73D4-4864-8E63-91780C418F9EQ28543934-29A4272A-C013-4139-B0DF-36B57AF47716Q35012585-3D82A44A-F1B0-4831-AE74-A3095831591CQ35219672-4BCF5AEE-6474-4D29-87B4-203F055E74E6Q35681274-D773B82A-9A8A-413D-AC0F-FCDDCC2ADD0CQ36019837-A7845A7A-13F3-40B7-875B-A088162C8F9BQ36220246-321DFE29-565B-45EF-BF55-8F9EA2E2446AQ36252883-9F3CFD1A-3FF7-41A6-9ED3-30C4771580C5Q36360219-22DC6881-CFB8-4C41-B7FC-CF341D5756A7Q36565063-4CEC4151-49D2-4FCF-A3AB-604A9E500781Q37055906-FAAE276B-3A9B-4B28-8451-8BD24B1D1C34Q37190965-026E8CA9-A6DB-4397-BDD8-BF08B896F6A7Q37473026-B8425915-F9E5-4717-B5E8-3627943AA808Q37524255-802CE319-47B5-470F-8066-82D5492CB53FQ37591097-C0D713D7-2A62-4437-9149-46A17DBA7823Q37872784-76F13E1E-3DAA-49CD-9EBB-0D58E71FEF26Q37981568-1DE125AB-FE8D-44C1-B56C-9EE60391BAD8Q37999650-F1195542-D292-4B68-BC2B-E5DECEAA682AQ38260525-AB55B1D6-C2BB-4E02-B708-4D89138CAB4FQ38473681-2267EBAA-46EA-45C3-ADBB-A5CE4BC5CAE6Q38563371-6808153E-31D7-4EED-9DB0-6DCBCAB4EE9EQ38942041-266A820C-8B1F-4369-B82C-69C4A320B230Q41127001-55670169-7AE7-439D-A388-D6CB1A899D49Q43006537-565FA4C4-9BDC-4283-8409-91523F8EE7F4Q43608412-AAAFF1F9-CADB-4361-9EAE-86A103EE65F7Q45391857-4B215333-3121-40D3-AD6A-1406AC449805Q46207754-C8EF8A05-7517-4AF2-B2B1-E48F8C4C9D01Q48092185-4D1B27A0-12FE-4D99-B423-C3089DFE4251Q53302806-1DB2FD66-906C-4FEC-AE1D-B84E89F11B63Q54240649-170B9AEE-16A2-4F0A-BDE9-0B4B9454C7DBQ54457383-8DD4AB36-3E5F-45C8-B1BF-50C75BE15566Q56035506-9AC60867-5E8E-40D7-B186-DC86F25123C7Q56773391-44350EBF-9B5D-4C05-B3C4-4A7F66903762Q58699244-FAC3CC26-EF1E-4B59-AD29-1540D98627FF
P2860
Unlicensed and off-label drug use in an Australian neonatal intensive care unit.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Unlicensed and off-label drug use in an Australian neonatal intensive care unit.
@ast
Unlicensed and off-label drug use in an Australian neonatal intensive care unit.
@en
Unlicensed and off-label drug use in an Australian neonatal intensive care unit.
@nl
type
label
Unlicensed and off-label drug use in an Australian neonatal intensive care unit.
@ast
Unlicensed and off-label drug use in an Australian neonatal intensive care unit.
@en
Unlicensed and off-label drug use in an Australian neonatal intensive care unit.
@nl
prefLabel
Unlicensed and off-label drug use in an Australian neonatal intensive care unit.
@ast
Unlicensed and off-label drug use in an Australian neonatal intensive care unit.
@en
Unlicensed and off-label drug use in an Australian neonatal intensive care unit.
@nl
P2093
P356
P1433
P1476
Unlicensed and off-label drug use in an Australian neonatal intensive care unit.
@en
P2093
Colin J Morley
Colm P F O'Donnell
Robyn J Stone
P356
10.1542/PEDS.110.5.E52
P407
P577
2002-11-01T00:00:00Z